Feasibility and diagnostic accuracy of a gated SPECT early-imaging protocol: A multicenter study of the myoview imaging optimization group

Journal of Nuclear Medicine

Volumn 48, Issue 10, 2007, Pages 1670-1675

  Giorgetti, Assuero ^a   Rossi, Massimiliano ^a   Stanislao, Mario ^a   Valle, Guido ^a   Bertolaccini, Pietro ^a   Maneschi, Alberto ^a   Giubbini, Raffaele ^a   De Rimini, Maria Luisa ^a   Mazzanti, Marco ^a   Cappagli, Mario ^a   Milan, Elisa ^a   Volterrani, Duccio ^a   Marzullo, Paolo ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Coronary artery disease; Delayed imaging; Early imaging; Gated SPECT; Myocardial imaging; Tetrofosmin

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ISOSORBIDE MONONITRATE; TETROFOSMIN TC 99M;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; FEASIBILITY STUDY; FEMALE; GATED IMAGING; HEART FUNCTION; HEART MUSCLE PERFUSION; HUMAN; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ARTERY DISEASE; FEASIBILITY STUDIES; FEMALE; GATED BLOOD-POOL IMAGING; HUMANS; ITALY; MALE; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 35348817414     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.106.039107     Document Type: Article

References (19)

1. Underwood SR, Anagnostopoulos C, Cerqueira M, et al. Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imaging. 2004;31:261-291.
2. Tamaki N, Morita K. SPET in cardiology: diagnosis, prognosis, and management of patients with coronary artery disease. Q J Nucl Med Mol Imaging. 2005;49:193-203.
3. Travin MI, Bergmann SR. Assessment of myocardial viability. Semin Nucl Med. 2005;35:2-16.
4. Jain D, Wackers FJT, Mattera J, McMahon M, Sinusas AJ, Zaret BL. Biokinetics of technetium-99m-tetrofosmin myocardial perfusion imaging agent: implication for one-day imaging protocol. J Nucl Med. 1993;34:1254-1259.
5. Higley B, Smith FW, Smith T, et al. Technetium-99m-1,2 bis (bis(2-ethoxyethyl) phosphino) ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med. 1993;34:30-38.
6. Germano G, Chua T, Kiat H, Areeda JS, Berman DS. A quantitative phantom analysis of artifacts due to hepatic activity in technetium-99m myocardial perfusion SPECT studies. J Nucl Med. 1994;35:356-359.
7. Nuyts J, Dupont P, Van den Maegdenbergh V, Vleugels S, Suetens P, Mortelmans L. A study of the liver-heart artifact in emission tomography. J Nucl Med. 1995;36:133-139.
8. Matsunari I, Tanishima Y, Taki J, et al. Early and delayed technetium-99m-tetrofosmin myocardial SPECT compared in normal volunteers. J Nucl Med. 1996;37:1622-1626.
9. Hesse B, Tagil K, Cuocolo A, et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging. 2005;32:855-897.
10. Germano G, Bermann DS. Clinical Gated Cardiac SPECT. Armhonk, NY: Futura Publishing Company; 1999.
11. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical assessment. Lancet. 1986;1:307-310.
12. Fleiss J. Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: Wiley and Sons; 1981.
13. Ferreira M, Ferrer-Antunes AI, Lima J. Fast ninety minute Tc-99m-tetrofosmin stress-rest imaging protocol: results on a small sample [abstract]. J Nucl Cardiol. 1999;part 2, 15:59.
14. Bateman TM, Cullom SJ. Attenuation correction single-photon emission computed tomography myocardial perfusion imaging. Semin Nucl Med. 2005;35:37-51.
15. Schulz G, Ostwald E, Kaiser HJ, wom Dahl J, Kleinhans E, Buell E. Cardiac stress-rest single-photon emission computed tomography with technetium 99m-labeled tetrofosmin: influence of washout kinetics on regional myocardial uptake values of the rest study with a 1-day protocol. J Nucl Cardiol. 1997;4:298-301.
16. 201Tl and 99Tcm-tetrofosmin for the detection of ischaemic heart disease and determination of the optimal imaging time of 99Tcm-tetrofosmin. Nucl Med Commun. 1998;19:119-126.
17. Ambrosio G, Betocchi S, Pace L, et al. Prolonged impairment of regional contractile function after resolution of exercise-induce angina: evidence of myocardial stunning in patients with coronary artery disease. Circulation. 1996;94:2455-2466.
18. Paul AK, Hasegawa S, Yoshioka J, et al. Characteristics of regional myocardial stunning after exercise in gated myocardial SPECT. J Nucl Cardiol. 2002;9:388-394.
19. Emmett L, Iwanochko RM, Freeman MR, Barolet A, Lee DS, Husain M. Reversible regional wall motion abnormalities on exercise technetium-99m-gated cardiac single photon emission computed tomography predict high-grade angiographic stenoses. J Am Coll Cardiol. 2002;39:991-998.